EP0716694A4 - Human glucagon-like 1 peptide receptor - Google Patents

Human glucagon-like 1 peptide receptor

Info

Publication number
EP0716694A4
EP0716694A4 EP94925207A EP94925207A EP0716694A4 EP 0716694 A4 EP0716694 A4 EP 0716694A4 EP 94925207 A EP94925207 A EP 94925207A EP 94925207 A EP94925207 A EP 94925207A EP 0716694 A4 EP0716694 A4 EP 0716694A4
Authority
EP
European Patent Office
Prior art keywords
peptide receptor
human glucagon
glucagon
human
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94925207A
Other languages
German (de)
French (fr)
Other versions
EP0716694A1 (en
Inventor
Michael P Graziano
Doreen A Borkowski
Gary G Chicchi
Patricia J Hey
Catherine D Strader
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0716694A1 publication Critical patent/EP0716694A1/en
Publication of EP0716694A4 publication Critical patent/EP0716694A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP94925207A 1993-08-09 1994-08-03 Human glucagon-like 1 peptide receptor Withdrawn EP0716694A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10451793A 1993-08-09 1993-08-09
US104517 1993-08-09
PCT/US1994/008913 WO1995004821A1 (en) 1993-08-09 1994-08-03 Human glucagon-like 1 peptide receptor

Publications (2)

Publication Number Publication Date
EP0716694A1 EP0716694A1 (en) 1996-06-19
EP0716694A4 true EP0716694A4 (en) 1997-06-04

Family

ID=22300913

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94925207A Withdrawn EP0716694A4 (en) 1993-08-09 1994-08-03 Human glucagon-like 1 peptide receptor

Country Status (4)

Country Link
EP (1) EP0716694A4 (en)
JP (1) JPH09501054A (en)
CA (1) CA2168448A1 (en)
WO (1) WO1995004821A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0901503A1 (en) * 1996-05-22 1999-03-17 Merck & Co., Inc. Synthetic glucagon binding proteins
US5889167A (en) * 1996-05-22 1999-03-30 Merck & Co., Inc. Synthetic glucagon binding proteins
DK0946591T3 (en) * 1996-12-13 2007-08-13 Nps Allelix Corp Cloned glucagon-like peptide-2 receptors
US8592553B2 (en) 1996-12-13 2013-11-26 Nps Pharmaceuticals, Inc. Cloned glucagon-like peptide-2 receptors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019175A1 (en) * 1992-03-25 1993-09-30 Bernard Thorens Receptor for the glucagon-like-peptide-1 (glp-1)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019175A1 (en) * 1992-03-25 1993-09-30 Bernard Thorens Receptor for the glucagon-like-peptide-1 (glp-1)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GRAZIANO MP ET AL: "Cloning and functional expression of a human glucagon-like peptide-1 receptor.", BIOCHEM BIOPHYS RES COMMUN, OCT 15 1993, 196 (1) P141-6, UNITED STATES, XP002028256 *
See also references of WO9504821A1 *

Also Published As

Publication number Publication date
WO1995004821A1 (en) 1995-02-16
EP0716694A1 (en) 1996-06-19
CA2168448A1 (en) 1995-02-16
JPH09501054A (en) 1997-02-04

Similar Documents

Publication Publication Date Title
ZA928511B (en) Peptides
EP0828751A4 (en) Human neuropeptide receptor
TW353911U (en) Chair
TW294941U (en) Chair
HU9502041D0 (en) New peptide
GB9414833D0 (en) Polypeptide
AU121085S (en) Chair
EP0689547A4 (en) Cloned human alpha1c adrenergic receptor
AU120796S (en) Chair
AU122040S (en) Chair
SG50679A1 (en) Chair
EP0716694A4 (en) Human glucagon-like 1 peptide receptor
EP0792282A4 (en) Human endothelin-bombesin receptor
AU121086S (en) Chair
AU122041S (en) Chair
GB9318105D0 (en) Receptor action
AU121293S (en) Chair
AU119673S (en) Chair
AU121250S (en) Chair
DE69405544D1 (en) 4'-0-sulfonylanthracyclinderivate
TW499913U (en) Improved chair mechanism
GB9324818D0 (en) Peptide
ZA953792B (en) Human neuropeptide receptor
GB9008361D0 (en) Modified peptide
GB9304930D0 (en) Graingier's denium sierum

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960311

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19970423

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20000908

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010320